Pharmaceutical company Vivera Pharmaceuticals stated on Wednesday that it will test airline passengers flying into the UAE in accordance with the country's requirement for travellers to prove they are not infected with COVID-19 under an agreement with Pure Health, UAE.
Pure Health, which operates the largest network of laboratories in the UAE and a healthcare solutions provider, has reportedly appointed Vivera to launch this pioneering project in the UAE to promote safe travel.
The UAE-issued regulations require all travellers flying into the UAE to provide proof of a negative COVID-19 test. Travellers without such a certificate are refused entry on to the flight.
According to the partnership, the system is similar to the ESTA process in the United States. The traveller visits screening.purehealth.ae, chooses a testing location, selects a time slot and completes the test at the agreed time and place. The test results are then transmitted to the UAE authorities who use the data to cross-reference and authorize arriving travellers against the border control database.
Nuevocor names new chief medical officer
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
REVIAN names new vice president of Healthcare Sales
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation
Soligenix announces agreement on design for second Phase 3 trial for HyBryte with EMA
Ratio Therapeutics names new chief business officer and director
Trevi Therapeutics names new vice president of Clinical Development
NeoImmuneTech names new president and chief executive officer